Is rare cancer care organized at national health system level? Multiple case study in six EU countries

Background: As a system of European Reference Networks (ERNs) emerges, we aimed to shed light on the processes through which reference centres (RCs) for rare cancers are embedded in national health systems, and to formulate hypotheses about which national care models favour equitable access for pati...

ver descrição completa

Detalhes bibliográficos
Autores: Prades, Joan, Trama, Annalisa, Casali, Paolo Giovanni, Emile, Jean-François, Gaspar, Nathalie, Janavicius, Ramunas, Janciauskiene, Rasa, Karjalainen, Sakari, Kopeckova, Katerina, Pylkkänen, Liisa, Svoboda, Marek, Borràs Andrés, Josep Maria
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Recursos:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/191296
Acesso em linha:https://hdl.handle.net/2445/191296
Access Level:acceso abierto
Palavra-chave:Càncer
Malalties rares
Sarcoma
Assistència sanitària
Cancer
Rare diseases
Medical care
id ES_bbeda8b62f6e9c2bd3d65e71dfd7f5db
oai_identifier_str oai:diposit.ub.edu:2445/191296
network_acronym_str ES
network_name_str España
spelling Is rare cancer care organized at national health system level? Multiple case study in six EU countries Prades, Joan Trama, Annalisa Casali, Paolo Giovanni Emile, Jean-François Gaspar, Nathalie Janavicius, Ramunas Janciauskiene, Rasa Karjalainen, Sakari Kopeckova, Katerina Pylkkänen, Liisa Svoboda, Marek Borràs Andrés, Josep Maria Càncer Malalties rares Sarcoma Assistència sanitària Cancer Rare diseases Medical care Background: As a system of European Reference Networks (ERNs) emerges, we aimed to shed light on the processes through which reference centres (RCs) for rare cancers are embedded in national health systems, and to formulate hypotheses about which national care models favour equitable access for patients. Methods We used a multiple-case-study design based on the experiences of Czechia, Finland, France, Italy, Lithuania and Spain. Using sarcoma as an example of rare cancer, 52 semi-structured interviews were conducted during six on-site visits. Results The comparative analysis showed substantial heterogeneity in the processes for formalising RCs status and in their levels of integration in the different health systems, but two models, namely, the centre-based and the network-based, can be envisaged at national level. RCs for rare cancers were legally established only in France and Spain. Expert clinicians cooperate in a structured way, using network mechanisms, in France and Italy, and these countries, plus Finland and Lithuania, had a referral system to facilitate patients' access from non-expert centres to RCs. Comparative analysis of the cases enabled the identification of key healthcare planning principles in instituting RCs at the national level, among them the need to stipulate the involvement of expert professionals in steering the rare cancer care system. Oxford University Press https://hdl.handle.net/2445/191296
title Is rare cancer care organized at national health system level? Multiple case study in six EU countries
spellingShingle Is rare cancer care organized at national health system level? Multiple case study in six EU countries
Prades, Joan
Càncer
Malalties rares
Sarcoma
Assistència sanitària
Cancer
Rare diseases
Medical care
title_short Is rare cancer care organized at national health system level? Multiple case study in six EU countries
title_full Is rare cancer care organized at national health system level? Multiple case study in six EU countries
title_fullStr Is rare cancer care organized at national health system level? Multiple case study in six EU countries
title_full_unstemmed Is rare cancer care organized at national health system level? Multiple case study in six EU countries
title_sort Is rare cancer care organized at national health system level? Multiple case study in six EU countries
author Prades, Joan
author_facet Prades, Joan
Trama, Annalisa
Casali, Paolo Giovanni
Emile, Jean-François
Gaspar, Nathalie
Janavicius, Ramunas
Janciauskiene, Rasa
Karjalainen, Sakari
Kopeckova, Katerina
Pylkkänen, Liisa
Svoboda, Marek
Borràs Andrés, Josep Maria
author_role author
author2 Trama, Annalisa
Casali, Paolo Giovanni
Emile, Jean-François
Gaspar, Nathalie
Janavicius, Ramunas
Janciauskiene, Rasa
Karjalainen, Sakari
Kopeckova, Katerina
Pylkkänen, Liisa
Svoboda, Marek
Borràs Andrés, Josep Maria
author2_role author
author
author
author
author
author
author
author
author
author
author
topic Càncer
Malalties rares
Sarcoma
Assistència sanitària
Cancer
Rare diseases
Medical care
topic_facet Càncer
Malalties rares
Sarcoma
Assistència sanitària
Cancer
Rare diseases
Medical care
description Background: As a system of European Reference Networks (ERNs) emerges, we aimed to shed light on the processes through which reference centres (RCs) for rare cancers are embedded in national health systems, and to formulate hypotheses about which national care models favour equitable access for patients. Methods We used a multiple-case-study design based on the experiences of Czechia, Finland, France, Italy, Lithuania and Spain. Using sarcoma as an example of rare cancer, 52 semi-structured interviews were conducted during six on-site visits. Results The comparative analysis showed substantial heterogeneity in the processes for formalising RCs status and in their levels of integration in the different health systems, but two models, namely, the centre-based and the network-based, can be envisaged at national level. RCs for rare cancers were legally established only in France and Spain. Expert clinicians cooperate in a structured way, using network mechanisms, in France and Italy, and these countries, plus Finland and Lithuania, had a referral system to facilitate patients' access from non-expert centres to RCs. Comparative analysis of the cases enabled the identification of key healthcare planning principles in instituting RCs at the national level, among them the need to stipulate the involvement of expert professionals in steering the rare cancer care system.
publishDate 2022
format article
status_str publishedVersion
url https://hdl.handle.net/2445/191296
eu_rights_str_mv openAccess
publisher Oxford University Press
institution Universidad de Barcelona
collection Dipòsit Digital de la UB
reponame_str Dipòsit Digital de la UB
instname_str Universidad de Barcelona
_version_ 1878739144268578817
publishDateSort 2022
author_browse Borràs Andrés, Josep Maria
Casali, Paolo Giovanni
Emile, Jean-François
Gaspar, Nathalie
Janavicius, Ramunas
Janciauskiene, Rasa
Karjalainen, Sakari
Kopeckova, Katerina
Prades, Joan
Pylkkänen, Liisa
Svoboda, Marek
Trama, Annalisa
publisherStr Oxford University Press
score 6,8972664